Zacks Investment Research on MSN

KYMR stock up as FDA grants fast track designation to asthma drug

Kymera Therapeutics KYMR announced that the FDA has granted a Fast Track designation to its lead candidate, KT-621, for the ...

Sanofi’s bispecific scores in respiratory diseases but fails in eczema

Two of Sanofi’s lunsekimig Phase II trials have met their primary endpoints in respiratory disease, while a study in atopic ...

SNY's Lunsekimig Succeeds in Asthma & CRSwNP Studies, Fails in Eczema

Sanofi posts strong mid-stage results for lunsekimig in asthma and CRSwNP but a setback in atopic dermatitis clouds the ...
Paulick Report on MSN

Monty Arrossa’s Carmoterol saga continues: Urine split sample destroyed, blood sample ‘not confirmed’

A hearing officer’s report for the California Horse Racing Board (CHRB), involving the disqualification of Grade 1-winning ...
The Clinton Herald

TO YOUR GOOD HEALTH: Explaining birdshot chorioretinopathy and its treatments

My niece was diagnosed with birdshot chorioretinopathy. Can you please explain what this is, which treatments are involved, and what the typical prognoses are? — P.Z.
Healthline

What’s the Difference Between Short-Acting and Long-Acting Bronchodilators? Answered by an Expert

Short-acting bronchodilators offer quick relief of respiratory symptoms, with effects lasting from 30 minutes to several hours. They are often used as a rescue medication. Long-acting bronchodilators ...
WebMD

Inhaled Steroids for COPD

Inhaled steroids aren’t the go-to treatment for COPD, so your doctor will likely prescribe a bronchodilator, too. This is medicine in an inhaler that relaxes your airway muscles to help you breathe ...
The Conversation

Using a blue inhaler alone is not enough to manage your asthma

Inhalers have been key to asthma management since the 1950s. The most common, salbutamol, comes in a familiar blue-coloured inhaler (or “puffer”). This kind of “rescue inhaler” brings quick relief ...
Nasdaq

Verona Pharma Presents Positive Phase 3 Analyses of Ohtuvayre® for COPD at ATS 2025

Verona Pharma plc has announced the upcoming presentation of ten posters at the American Thoracic Society Conference 2025, highlighting analyses from its Phase 3 ENHANCE studies of Ohtuvayre ...
Healio

Odds for bronchodilator responsiveness lower in afternoon vs. morning hours

Please provide your email address to receive an email when new articles are posted on . Spirometry testing in the afternoon vs. morning was linked to a decreased likelihood for bronchodilator ...
Monthly Prescribing Reference

Bronchodilator Responsiveness Positivity More Likely in Morning

And compared with the rest of the year, bronchodilator responsiveness was more common in winter months. HealthDay News — Patients are more likely to have positive bronchodilator responsiveness in the ...
Yahoo

Top Quarter Horse Trainer Has Four Positives For Experimental Bronchodilator

Add Yahoo as a preferred source to see more of our stories on Google. The California Horse Racing Board's website reports that Quarter Horse trainer Monty Arrossa's trainees have returned four ...